The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 09, 2021

Filed:

Feb. 16, 2016
Applicants:

Universidade DE Santiago DE Compostela, A Coruña, ES;

Servizo Galego DE Saude (Sergas), A Coruña, ES;

Inventors:

María Isabel Lema Gesto, A Coruña, ES;

José Antonio Castillo Sánchez, A Coruña, ES;

Tomás Sobrino Moreiras, A Coruña, ES;

Francisco Campos Perez, A Coruña, ES;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/577 (2006.01); G01N 33/68 (2006.01); C12Q 1/68 (2018.01); C07K 14/705 (2006.01); C12Q 1/6876 (2018.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); C07K 14/705 (2013.01); C07K 14/70596 (2013.01); C12Q 1/68 (2013.01); C12Q 1/6876 (2013.01); G01N 33/50 (2013.01); G01N 33/5044 (2013.01); G01N 33/53 (2013.01); G01N 33/577 (2013.01); G01N 33/68 (2013.01); G01N 2800/16 (2013.01);
Abstract

The invention relates to the field of the diagnosis and prognosis methods of molecular pathologies. In particular, the invention relates to methods for determining the diagnosis of an ectatic disease of the cornea in a subject, for determining the risk of developing an ectatic disease of the cornea in a subject, for determining the clinical outcome of a subject suffering from an ectatic disease of the cornea and for selecting a subject to be treated with a therapy for an ectatic disease of the cornea based on the determination of the expression levels of TLR2 and/or TLR4 markers. The invention also relates to the use of the TLR2 and/or TLR4 as diagnosis and prognosis markers for an ectatic disease of the cornea.


Find Patent Forward Citations

Loading…